Correction: Cytochrome P450 1B1 inhibition suppresses tumorigenicity of prostate cancer via caspase-1 activation.
Chang I, Mitsui Y, Kim SK, Sun JS, Jeon HS, Kang JY, Kang NJ, Fukuhara S, Gill A, Shahryari V, Tabatabai ZL, Greene KL, Dahiya R, Shin DM, Tanaka Y.
Chang I, et al. Among authors: tanaka y.
Oncotarget. 2018 Sep 25;9(75):34190. doi: 10.18632/oncotarget.26197. eCollection 2018 Sep 25.
Oncotarget. 2018.
PMID: 30344932
Free PMC article.